Latest Cancer Research Stories
A new study published in The Oncologist found that genetically engineered mouse models appear to be the most accurate preclinical predictor of how cancer-fighting drugs are delivered to melanoma patients. The study, led by UNC-Chapel Hill researchers along with colleagues in the Research Triangle Park, Pittsburgh and Austria, tested how four different types of mouse models predict the delivery of carboplatin, a commonly used anticancer drug, to melanoma tumors in patients. Durham, NC...
VABC releases a statement following reports that suggest new available therapies may potentially offer hope to patients with brain tumors Bohemia, NY (PRWEB) September 19, 2012 On September 19, 2012, nonprofit organization Voices Against Brain Cancer (VABC) commented on an article suggesting that new therapies may potentially offer new hope to patients with brain tumors. According to an article in The Augusta Chronicle by Tom Corwin, cancer patient Olivia Mitchell’s battle against her...
WASHINGTON, Sept. 19, 2012 /PRNewswire-USNewswire/ -- The following is being released by the National Press Club: (Logo: http://photos.prnewswire.com/prnh/20080917/NPCLOGO) Date: Tuesday, Sept. 25Time: 10 a.m.Place: National Press Club, 529 14th St. NW, Washington, D.C. 20045 Nobel Laureate Dr. Harold Varmus, director of the National Institutes of Health's National Cancer Institute, will discuss the barriers that impede the nation's ability to make faster progress against...
The Vall d'Hebron Breast Cancer Unit, the Vall d'Hebron Institute of Oncology (VHIO) and SOLTI, an academic breast cancer research group are heading up a multi-center international study involving four Spanish and three North American research centers. The aim of the study is to investigate whether BKM120, a drug that inhibits the PI3K pathway (phosphatidylinositol-3-Kinase) can be an effective treatment against triple-negative breast cancer. At present it is known that breast cancer can...
Connie K. Ho for redOrbit.com – Your Universe Online Two new studies published in the journal of the American Association for Cancer Research discovered that assessments of the human papillomavirus (HPV) that test for a single DNA biomarker alone are a weak indicator for determining the risk of HPV-driven head and neck cancers. On the other hand, the studies point to a combination of genetic markers that may provide a more robust test. Past research has found that HPV can lead to...
NEW YORK, Sept. 19, 2012 /PRNewswire/ -- Online registration is now open for Cycle for Survival, Memorial Sloan-Kettering Cancer Center's national indoor team cycling event that has raised more than $17 million for rare cancer research, funding more than 50 clinical trials and research studies since 2007. Cycle 2013 is expected to be the largest event yet, spanning 10 locations in eight states and bringing together more than 13,000 cyclers nationwide. The 2013 event schedule is as...
Human papillomavirus (HPV) has long been implicated in cervical cancer, but details of how it happens have remained a mystery. Now researchers at the University of Wisconsin-Madison have found that a single HPV protein is required for cervical cancer and even pre-cancer growths in the cervix to survive. In anticipation of a clinical trial in humans, the scientists and their collaborators are moving quickly to test if a gene-silencing technique could cripple the protein and eliminate...
PicturesOnGold.com released a new collection of “Childhood Cancer Awareness Jewelry”. The idea was created in recognition of September National Childhood Cancer Awareness Month, and a new partnership with Mystic Force Foundation, Inc. a 501(c)(3) tax exempt nonprofit public charity Tax ID# 26-2454734. Staten Island, NY (PRWEB) September 14, 2012 In recognition of National September Childhood Cancer Awareness Month, PicturesOnGold.com has created a new collection of “Childhood...
A whole-genome scan to identify large-scale chromosomal damage can help doctors choose the best treatment option for children with neuroblastoma, one of the most common types of childhood cancer, finds an international collaboration jointly led by The Institute of Cancer Research, London. The researchers called for all children diagnosed with neuroblastoma worldwide to have a whole-genome scan as a standard part of their treatment. Neuroblastoma, a cancer of the developing nervous...
LA JOLLA, Calif., Sept. 13, 2012 /PRNewswire-USNewswire/ -- The Salk Institute announced today that researchers Bjorn Lillemeier, and Axel Nimmerjahn, have been named recipients of the prestigious 2012 National Institutes of Health (NIH) Director's New Innovator Award. The NIH Director's New Innovator Award is a highly selective program with hundreds of researchers from the nation's top scientific institutions competing for the award. Only 51 scientists received the honor this year....
